Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
批准号:
9906180
负责人:
Daniel L. Marks
金额:
$43.98万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-10 至 2023-04-30
关键词:
AcuteAddressAmplifiersAnimal ModelAnorexiaAttenuatedAutomobile DrivingBehaviorBehavioralBiochemicalBlood - brain barrier anatomyBody Weight decreasedBrainCachexiaCancer PatientCatabolismCause of DeathCell Culture TechniquesChronicChronic DiseaseClinical TrialsCollaborationsDataDesire for foodDevelopmentDiseaseEndocrineExposure toFatigueFlow CytometryGoalsHypothalamic structureIn VitroIndividualInflammationInflammatoryInflammatory ResponseInterventionLaboratoriesLeadLethargiesLeukocytesLifeLigandsLinkMaintenanceMalignant neoplasm of pancreasMalnutritionMediator of activation proteinMetabolicMetabolic syndromeMetabolismMicroRNAsMicrogliaModelingMolecularMorbidity - disease rateMotivationMuscleMuscular AtrophyNeuraxisNeuroendocrinologyNeuronsNeurosciencesOrganPancreatic Ductal AdenocarcinomaPathway interactionsPatientsPeripheralPharmacologic SubstancePopulationProcessProductionPropertyQuality of lifeResearchResourcesRoleSavingsSensorySeveritiesSick RoleSignal PathwaySignal TransductionSignaling MoleculeSyndromeTLR7 geneTechniquesTestingTherapeutic InterventionTissuesToll-like receptorsTreatment EfficacyTumor-DerivedWorkcancer cachexiacytokinedesigneffective therapyexosomeextracellular vesiclesimprovedin vivoinnovationlean body masslipid metabolismmortalitymortality riskmouse modelneuroinflammationneurotransmissionnovelnovel therapeuticspancreatic cancer patientsrecruitresponsesensortherapeutic targettumorwasting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary:
Illness behaviors and metabolic disturbances are common in pancreatic cancer patients, and may lead to
wasting or cachexia. This devastating state of malnutrition is brought about by a synergistic combination of a
decrease in appetite and an increase in metabolism of fat and lean body mass. The severity of cachexia in
many illnesses is the primary determining factor in both quality of life, and in eventual mortality. Other illness-
induced morbidities including lethargy also compromise the ability of patients to recover from life-saving or
extending interventions, and diminish the motivational drive to aggressively battle the condition. Although
cachexia in cancer patients was described more than two thousand years ago, the central mechanisms
underlying this disorder are poorly understood. Furthermore, there is currently no effective pharmaceutical
treatment. Our laboratory is dedicated to unraveling the basic neuroscience of cachexia. In this proposal, we
will focus on understanding the scope and mechanism by which signals of pancreatic cancer development are
received, amplified, and maintained by the hypothalamus. The significance of this proposal resides in its
unique combination of our historical focus on neuroendocrinology and behavior, with new collaborations and
efforts directed at understanding the role of extracellular vesicles in neuroinflammation. The long-term goal of
our research is to gain mechanistic understanding of the acute illness response and how it is transitioned into
chronic inflammation-associated cachexia in order to develop more effective therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
-
批准号:10303658
-
项目类别:
-
资助金额:$43.28万
-
财政年份:2021
-
负责人:Daniel L. Marks
-
依托单位:
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia
-
批准号:10379260
-
项目类别:
-
资助金额:$38.58万
-
财政年份:2021
-
负责人:Daniel L. Marks
-
依托单位:
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia
-
批准号:10152268
-
项目类别:
-
资助金额:$39.37万
-
财政年份:2021
-
负责人:Daniel L. Marks
-
依托单位:
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
-
批准号:10490306
-
项目类别:
-
资助金额:$42.41万
-
财政年份:2021
-
负责人:Daniel L. Marks
-
依托单位:
Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
-
批准号:10171402
-
项目类别:
-
资助金额:$43.98万
-
财政年份:2018
-
负责人:Daniel L. Marks
-
依托单位:
Exosomes as Endocrine Signaling Molecules in Cancer Cachexia
-
批准号:10394305
-
项目类别:
-
资助金额:$43.1万
-
财政年份:2018
-
负责人:Daniel L. Marks
-
依托单位:
(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
-
批准号:8994016
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2014
-
负责人:Daniel L. Marks
-
依托单位:
(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
-
批准号:8845181
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2014
-
负责人:Daniel L. Marks
-
依托单位:
(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
-
批准号:9079439
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2014
-
负责人:Daniel L. Marks
-
依托单位:
(PQD6) Hypothalamic Inflammation in the Initiation of Cachexia
-
批准号:8680933
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2014
-
负责人:Daniel L. Marks
-
依托单位:
EVOLUTION OF INSULIN RESISTANCE
-
批准号:7206608
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2005
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:8058687
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:7885233
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:7920640
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:6900231
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:7235331
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:8441602
-
项目类别:
-
资助金额:$30.86万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:7068044
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:8249437
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
Hypothalamic Mechanisms in Cachexia
-
批准号:7429671
-
项目类别:
-
资助金额:$25.3万
-
财政年份:2004
-
负责人:Daniel L. Marks
-
依托单位:
海外基金